DARA induces the release of CD38 from myeloma cells by microvesicles [35] and the CD38 expression on MM cells is decreased after DARA exposure due to the process called trogocytosis, where there is the transfer of CD38 of MM cells to monocytes and granulocytes [36]. This evidence concerns the gene CD38 and plasma cell myeloma.